SPNC Profile
The Spectranetics Corporation (SPNC) was a medical technology company that focused on developing and commercializing innovative devices used in minimally invasive procedures within the cardiovascular system. The company was based in Colorado Springs, Colorado, and had operations in several countries around the world. In August 2017, the company was acquired by Philips for approximately $2.2 billion.
SPNC offered a range of products and services for the treatment of various cardiovascular conditions, including atherectomy systems, laser ablation catheters, thrombectomy systems, and other vascular intervention technologies. These devices were designed to provide physicians with enhanced precision and control during procedures, ultimately leading to better patient outcomes.
The company's products were used in a variety of procedures, including the treatment of peripheral artery disease (PAD), coronary artery disease (CAD), and the removal of blood clots from vessels. SPNC also offered support and training to healthcare professionals using its products, with the aim of improving patient care and outcomes.
In addition to its products and services, SPNC conducted research and development activities aimed at discovering and developing new technologies for the treatment of cardiovascular diseases. The company collaborated with leading medical institutions and research organizations to identify new treatment approaches and bring them to market.
Overall, SPNC was a leading player in the cardiovascular medical device industry, with a strong reputation for developing innovative and effective technologies for use in minimally invasive procedures. The company's acquisition by Philips represents a significant development in the field of cardiovascular medicine, and is expected to result in further advancements in the diagnosis and treatment of cardiovascular disease.
|
